Market Highlights

The Middle East and Africa Clinical Trial Imaging Market Research has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future. Clinical trial is major process in drug development process. Drug development process is expensive and need huge funding. Imaging perform different functions in clinical trials like detection, characterization, and monitoring or assessment. Pharmaceutical and biotechnology companies investing in RD to develop new drugs which further observed and make available to the public. Imaging also plays important role to minimize the cost of clinical trials. Imaging is a natural fit for early phase trials, since they are more dynamic and involve more scientific work than later-phase trials. Imaging biomarkers to increase the probability of success in clinical trials and to evaluate efficacy more rapidly. Increasing number of non-communicable diseases, improved healthcare infrastructure, and government initiatives are leading the growth for clinical trial imaging market in Middle East and Africa. However, there are some factors affecting the growth for clinical trial imaging market in Middle East and Africa such as inaccurate data collection, improper data sharing, expensive drug development process, limited access to the advance imaging technology, delays in trial, strict government regulations etc.

Middle-East and Africa Clinical trial imaging Market was estimated of US$ 76.1 million in 2022 and expected to reach US$ 115.6 million by 2030 at a CAGR of 6.1%.

Segmentation:

Middle East and Africa clinical trial imaging market has been segmented

On the basis of products which comprises of Services, Software, and others.

On the basis of modality, the market is segmented into X-Ray, Ultrasound, CT, PET, MRI, Echocardiography, and others.

On the basis of end user, the market segmented into pharmaceutical companies, biotech companies, research centers, hospitals and others.

Middle-East and Africa Clinical trial imaging Market Players:

There are plenty of large and small market players which operate in this market all over the Middle East and Africa region, such as Bioclinica, Inc. (US), Cardiovascular Imaging Technologies, LLC (US), Parexel International Corporation (US), Biomedical Systems Corporation (US), Icon PLC (Republic of Ireland), Intrinsic Imaging LLC (US), Biotelemetry, Inc. (US), Intrinsic Imaging LLC (US), Parexel International Corporation (US).

Regional Analysis:

Considering the Middle-East and Africa Clinical trial imaging Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Clinical trial imaging market. Moreover Saudi Arabia market is also growing and second largest market for Clinical trial imaging. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Clinical trial imaging market during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013